Product Images Zaltrap
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Zaltrap NDC 0024-5841 by Sanofi-aventis U.s. Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - zaltrap 01
PRINCIPAL DISPLAY PANEL - 100 mg/4 mL Vial Carton - zaltrap 02
The text is a set of instructions and details related to Zaltrap medication. It is administered through intravenous infusion only and should not be given by other routes. It is hyperosmotic and must be diluted before use. The patient is advised to discard any unused portion, and the medication should be stored refrigerated at 2-8°C and protected from light. The package insert provides information about dosage and administration. It contains 100mg of Snliawents US uc.*
PRINCIPAL DISPLAY PANEL - 200 mg/8 mL Vial Carton - zaltrap 03
ZALTRAP (ziv-aflibercept) is an injection for intravenous infusion only. Each vial contains 200 ml of zivaflibercept in a solution of 25 mg/ml. It is hyperosmotic and must be diluted. The medication is intended for intravenous use only, and the unused portion should be discarded. It is important to store it at refrigerated temperatures (36-46°F) and protect it from light. The dosage and administration are outlined in the package insert. ZALTRAP is a registered trademark of Regeneron Pharmaceutical Inc.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.